(19)
(11) EP 1 370 265 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
30.10.2013 Bulletin 2013/44

(45) Mention of the grant of the patent:
25.07.2007 Bulletin 2007/30

(21) Application number: 02740421.9

(22) Date of filing: 13.03.2002
(51) International Patent Classification (IPC): 
A61K 31/4965(2006.01)
C07D 241/20(2006.01)
 A61P 31/18(2006.01)
(86) International application number:
PCT/EP2002/002806
(87) International publication number:
WO 2002/078708 (10.10.2002 Gazette 2002/41)

(54)

HIV INHIBITING PYRAZINONE DERIVATIVES

HIV HEMMENDE PYRAZINON-DERIVATE

DERIVES DE PYRAZINONE DESTINES A INHIBER LE VIH

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 15.03.2001 EP 01200971

(43) Date of publication of application:
17.12.2003 Bulletin 2003/51

(73) Proprietor: Janssen Pharmaceutica NV
2340 Beerse (BE)

(72) Inventors:
  • JANSSEN, Paul, Adriaan, Jan, Janssen Pharm. N.V.
    B-2340 Beerse (BE)
  • VAN AKEN, Koen, Jeanne, Alfons
    B-8500 Kortrijk (BE)
  • LEWI, Paulus, Joannes, Janssen Pharmaceutica N.V.
    B-2340 Beerse (BE)
  • KOYMANS, Lucien, Maria, H., Janssen Pharm. N.V.
    B-2340 Beerse (BE)
  • DE JONGE, Marc René
    2264 BH Leidschendam (NL)
  • HEERES, Jan, Janssen Pharmaceutica N.V.
    B-2340 Beerse (BE)
  • DAEYAERT, Frederik, Frans, D., Janssen Pharm. N.V.
    B-2340 Beerse (BE)
  • HOORNAERT, Georges, J., C., K.U.Leuven Res. & Dev.
    B-3000 Leuven (BE)
  • COMPERNOLLE, Frans, J., C., K.U.Leuven Res.&Dev.
    B-3000 Leuven (BE)
  • KILONDA, Amuri, K.U.Leuven Research & Development
    B-3000 Leuven (BE)

(74) Representative: Quaghebeur, Luc et al
Janssen Pharmaceutica N.V., J&J Patent Law Department, Turnhoutseweg 30
2340 Beerse
2340 Beerse (BE)


(56) References cited: : 
EP-A- 0 462 800
GB-A- 2 266 716
 WO-A-98/11075
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).